期刊文献+

一种新阿片肽的分离纯化 被引量:3

Separating and Purification of a New Opioid Peptide
下载PDF
导出
摘要 报道了一种新阿片肽OP1的分离纯化。将重组毕赤酵母经适宜的生长和表达培养后,所得的发酵液经离心得无细胞上清液,上清液经超滤后过Sephadex G-10柱。将经Sephadex G-10柱所得具有阿片活性的粗组分用HPLC-MS分析,根据阿片肽N-端均有一个酪氨酸残基,且在肽链的第三或第四位上有一个芳香族氨基酸残基这一性质,依据分子量确定活性组分中可能存在的所有阿片肽,然后根据这些阿片肽的等电点,利用AKTA Purifier 100快速纯化系统的DEAE-阴离子交换纤维素柱将其进一步分离,活性组分再用Sephasil peptide C18反相高压液相柱分离得到活性组分OP1肽,鉴定纯度后测定其氨基酸组成。最后确定该肽的一级序列为YPFPGPIRYG,该阿片肽序列目前尚未见报道。 A new opioid peptide, OP1, was obtained by separating and purification. Supernatant was collected by centrifugation from the recombinant Pichia pastoris fermented. The supernatant was ultrafiltrated and then separated by Sephadex G-10 chromatography. On account of the common structural feature among endogenous and exogenous opioid peptides, that is, the presence of a tyrosine residue at the amino terminal end and the presence of another aromatic residue , e.g. phenylalanine or tyrosine, in the third or fourth position, all potential existent opioid peptides in zymotic supernatant can be obtained. According to the molecular weight of these opioid peptides identified by HPLC-MS, all possible opioid peptides in active component were ascertained. Depending on pI and the molecular weight of these opioid peptides, the active component was purified by the AKTA-100 Purifier system with DEAE-cellulose ion exchange chromatography and Sephasil peptide C18 reversed phase chromatography. The peptide OP1 was obtained finally. The OP1 showed one peak on capillary electrophoresis. The amino acid composition of OP1 was determined. The sequence of OP1 was YPFPGPIRYG.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2005年第2期31-34,44,共5页 China Biotechnology
基金 中央级科研院所基础性工作专项资金项目-重点项目(2100DEA20022)
关键词 阿片肽 OP 上清液 残基 高压液相 HPLC 表达 活性组分 阴离子交换纤维 发酵液 A new opioid peptide Separating Purification
  • 相关文献

参考文献10

  • 1张源淑,陈伟华,邹思湘.酪蛋白源阿片物质的分离、纯化及活性鉴定[J].南京农业大学学报,1999,22(4):81-83. 被引量:15
  • 2阮林,毕好生.阿片类药物的外周镇痛作用[J].国外医学(麻醉学与复苏分册),2002,23(6):338-341. 被引量:9
  • 3杜月城.神经肽和脑功能[M].上海:上海教育出版社,1998.168. 被引量:1
  • 4邬小兵,乐国伟,施用晖.重组小分子多肽的SDS-PAGE分析方法[J].无锡轻工大学学报(食品与生物技术),2003,22(1):93-95. 被引量:2
  • 5Zaki P A, Bilsky E J, Vanderak T W,et al. Opioid receptor types and subtypes: the dalta receptor as a model. Annual Reviews on Pharmacology and Toxicology, 1996, 36:379 ~ 401. 被引量:1
  • 6Takahashi K, Takai T, Yasuhara T, et al. Effect of site-directed mutagenesis in the cysteine residues and the N-glycosylation motif in recombinant Der f 1 on secretion and protease activity.International Arch Allergy Immunology, 2001,124(4) :454 ~ 460. 被引量:1
  • 7Kotayash K, Kuwae S, Ohya T, et al. High level expression of recombinant human serum albumin from the methylotrophic yeast Pichia Pastotis with minimal protease production and activation.Journal Bilsci Bioeng, 2000,89:55 ~ 61. 被引量:1
  • 8Mierke D F, Nobner G, Schiller P W, et al. Morphiceptin analogs containing 2-aminocyclopentane carboxylic acid as a peptidomimetic for proline. International Journal of Peptide Research, 1990, 35:34 ~ 45. 被引量:1
  • 9Hugbers J, Smith T W, Kosteriitz H W, et al. Identification of two related penta-peptides from the brain with potent opiate agonist activity. Nature,1975, 258:577 ~ 579. 被引量:1
  • 10Mutsuko N, Masaaki K, Masahiro O, et al. High-performance liquid chromatography of N-terminal tyrosine-containing oligopeptides by pre-column fluorescence derivatization with hydroxylamine, cobalt (Ⅱ) and borate reagents. Journal of Chromatography, 1987, 411:305 ~ 311. 被引量:1

二级参考文献8

共引文献23

同被引文献77

  • 1洪新如.下丘脑室旁核β-内啡肽在大鼠烫伤休克中的作用及其受体机制的研究[J].生理科学进展,1993,24(3):242-244. 被引量:10
  • 2王秀丽,米卫东.阿片肽及糖皮质激素与疼痛的神经免疫调节[J].中华老年多器官疾病杂志,2005,4(2):141-145. 被引量:4
  • 3韩翔,王萍,董强.阿片肽、阿片受体及其拮抗剂在中枢神经系统中的作用[J].神经损伤与功能重建,2006,1(2):112-113. 被引量:11
  • 4Antila P., Paakari I., Jarvinen A., et al. Opioid peptides derived from in-vitro proteolysis of bovine whey proteins. International Dairy Journal, 1991, 1(4): 215-229. 被引量:1
  • 5Reinscheid R. K., Nothacker H. E, Bourson A., et al. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 1995, 270(5337): 792-794. 被引量:1
  • 6Zadina J. E., Hackler L., Ge L. J., et al. A potent and selective endogenous agonist for the mu-opiate receptor. Nature, 1997, 386(6624): 499-502. 被引量:1
  • 7Perpetuo E. A., Juliano L., Lebrun I.. Biochemical and pharmacological aspects of two bradykinin- potentiating peptides obtained from tryptic hydrolysis of casein. Journal of Protein Chemistry, 2003, 22(7-8): 601-606. 被引量:1
  • 8Honda T., Shirasu N., Isozaki K., et al. Differential receptor binding characteristics of consecutive phenylalanines in μ-opioid specific peptide ligand endomorphin-2. Bioorganic &Medicinal Chemistry, 2007, 15(11): 3883-3888. 被引量:1
  • 9Szatmari I., Biyashev D., Tomboly C., et al. Influence of degradation on binding properties and biological activity of endomorphin-1. Biochemical and Biophysical Research Communications, 2001, 284(3): 771-776. 被引量:1
  • 10Fichna J., Janecka A., Bailly L., et al. In vitro characterization of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brain. Chemical Biology & Drug Design, 2006, 68(3): 173-175. 被引量:1

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部